Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Standifer

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Methods in Enzymology|November 24, 1999
Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatmentK M Standifer
Neuropharmacology|November 9, 2002
Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposureD R Thakker, K M Standifer
Cellular Signalling|May 1, 1997
G proteins and opioid receptor-mediated signallingK M Standifer, G W Pasternak
Trends in Pharmacological Sciences|October 1, 1995
Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacologyG W Pasternak, K M Standifer
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1989
Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitroK M Standifer, J Pitha, S P Baker
Visual Neuroscience|April 6, 2000
GABA(A) receptor binding and localization in the tiger salamander retinaH Wang, K M Standifer, D M Sherry
Biochemical Pharmacology|July 15, 1990
Modulation of mu 1, mu 2, and delta opioid binding by divalent cationsK Kinouchi, K M Standifer, G W Pasternak
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformationsK M Standifer, J A Clark, G W Pasternak
The Journal of Comparative Neurology|February 27, 2001
Vesicle-associated membrane protein isoforms in the tiger salamander retinaD M Sherry, H Yang, K M Standifer
European Journal of Pharmacology|August 15, 2000
beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cellsC D Mandyam, G F Altememi, K M Standifer
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Methods in Enzymology|November 24, 1999
Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatmentK M Standifer
Neuropharmacology|November 9, 2002
Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposureD R Thakker, K M Standifer
Cellular Signalling|May 1, 1997
G proteins and opioid receptor-mediated signallingK M Standifer, G W Pasternak
Trends in Pharmacological Sciences|October 1, 1995
Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacologyG W Pasternak, K M Standifer
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1989
Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitroK M Standifer, J Pitha, S P Baker
Visual Neuroscience|April 6, 2000
GABA(A) receptor binding and localization in the tiger salamander retinaH Wang, K M Standifer, D M Sherry
Biochemical Pharmacology|July 15, 1990
Modulation of mu 1, mu 2, and delta opioid binding by divalent cationsK Kinouchi, K M Standifer, G W Pasternak
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformationsK M Standifer, J A Clark, G W Pasternak
The Journal of Comparative Neurology|February 27, 2001
Vesicle-associated membrane protein isoforms in the tiger salamander retinaD M Sherry, H Yang, K M Standifer
European Journal of Pharmacology|August 15, 2000
beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cellsC D Mandyam, G F Altememi, K M Standifer
Pageof 4